The role of reactive oxygen species in tumor treatment

Pengpeng Jia1, Chenyu Dai1, Penghui Cao1

  • 1Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China ouyangrz@usst.edu.cn.

RSC Advances
|May 2, 2022
PubMed

Insights

Reactive oxygen species (ROS) are crucial signaling molecules involved in cancer. This review explores how manipulating ROS levels offers promising strategies for tumor treatment and prevention.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • Reactive oxygen species (ROS) are metabolic by-products and signaling molecules regulating biological processes.
  • Tumor occurrence, growth, metastasis, and cell death (apoptosis, necrosis, autophagy) are closely linked to ROS.
  • While ROS are essential for homeostasis, oxidative stress-induced ROS can damage cellular components.

Purpose of the Study:

  • To review recent research on tumor treatments utilizing ROS.
  • To analyze mechanisms by which ROS inhibit tumors and affect the tumor microenvironment.
  • To summarize ROS detection methods, challenges, and solutions in cancer research.

Main Methods:

  • Literature review of recent studies on ROS and cancer treatment.
  • Analysis of ROS-mediated anti-tumor mechanisms.
  • Summary of ROS detection techniques and research challenges.

Main Results:

  • ROS play a dual role in cancer, acting as both signaling molecules and damaging agents.
  • Targeting ROS levels has shown significant potential in cancer therapy.
  • Understanding ROS dynamics is key to developing effective cancer treatments.

Conclusions:

  • Manipulating ROS presents a viable strategy for cancer treatment.
  • Further research into ROS detection and modulation can inspire novel cancer prevention and therapy approaches.
  • This review provides insights into the complex role of ROS in oncology.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
687
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K